BCRX
Price
$8.35
Change
-$0.25 (-2.91%)
Updated
Aug 7 closing price
Capitalization
1.75B
82 days until earnings call
PBM
Price
$4.18
Change
+$0.09 (+2.20%)
Updated
Aug 7 closing price
Capitalization
2.98M
Interact to see
Advertisement

BCRX vs PBM

Header iconBCRX vs PBM Comparison
Open Charts BCRX vs PBMBanner chart's image
BioCryst Pharmaceuticals
Price$8.35
Change-$0.25 (-2.91%)
Volume$2.33M
Capitalization1.75B
Psyence Biomedical
Price$4.18
Change+$0.09 (+2.20%)
Volume$207.64K
Capitalization2.98M
BCRX vs PBM Comparison Chart in %
Loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCRX vs. PBM commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCRX is a Hold and PBM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (BCRX: $8.35 vs. PBM: $4.18)
Brand notoriety: BCRX: Notable vs. PBM: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCRX: 64% vs. PBM: 9%
Market capitalization -- BCRX: $1.75B vs. PBM: $2.98M
BCRX [@Biotechnology] is valued at $1.75B. PBM’s [@Biotechnology] market capitalization is $2.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCRX’s FA Score shows that 0 FA rating(s) are green whilePBM’s FA Score has 1 green FA rating(s).

  • BCRX’s FA Score: 0 green, 5 red.
  • PBM’s FA Score: 1 green, 4 red.
According to our system of comparison, both BCRX and PBM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCRX’s TA Score shows that 5 TA indicator(s) are bullish while PBM’s TA Score has 3 bullish TA indicator(s).

  • BCRX’s TA Score: 5 bullish, 3 bearish.
  • PBM’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BCRX is a better buy in the short-term than PBM.

Price Growth

BCRX (@Biotechnology) experienced а +2.58% price change this week, while PBM (@Biotechnology) price change was -16.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

BCRX is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCRX($1.75B) has a higher market cap than PBM($2.98M). BCRX YTD gains are higher at: 11.037 vs. PBM (-75.144). BCRX has higher annual earnings (EBITDA): 47.6M vs. PBM (-46.56M). BCRX has more cash in the bank: 295M vs. PBM (1.93M). PBM has less debt than BCRX: PBM (2.5M) vs BCRX (795M). BCRX has higher revenues than PBM: BCRX (503M) vs PBM (0).
BCRXPBMBCRX / PBM
Capitalization1.75B2.98M58,806%
EBITDA47.6M-46.56M-102%
Gain YTD11.037-75.144-15%
P/E RatioN/A0.10-
Revenue503M0-
Total Cash295M1.93M15,261%
Total Debt795M2.5M31,787%
FUNDAMENTALS RATINGS
BCRX: Fundamental Ratings
BCRX
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCRXPBM
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend about 1 month ago
79%
Bullish Trend 15 days ago
88%
Declines
ODDS (%)
Bearish Trend 8 days ago
80%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBMBX18.86N/A
N/A
Neuberger Berman Mid Cap Growth Adv
IMORX18.02N/A
N/A
Voya MidCap Opportunities R
MECIX55.13N/A
N/A
AMG GW&K International Small Cap I
HILRX22.88N/A
N/A
Hartford International Value R3
OFVIX20.70N/A
N/A
O'Shaughnessy Market Leaders Value I

PBM and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBM has been loosely correlated with NRSN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PBM jumps, then NRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBM
1D Price
Change %
PBM100%
+2.20%
NRSN - PBM
36%
Loosely correlated
-2.99%
ATHA - PBM
28%
Poorly correlated
-2.37%
BCRX - PBM
27%
Poorly correlated
-2.91%
CRBU - PBM
26%
Poorly correlated
-3.72%
IPSC - PBM
25%
Poorly correlated
-2.43%
More